[Federal Register Volume 60, Number 62 (Friday, March 31, 1995)]
[Rules and Regulations]
[Pages 16570-16571]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-7865]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES
21 CFR Part 510


Animal Drugs, Feeds, and Related Products; Change of Sponsor Name 
and Address

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
drug regulations to reflect a change of sponsor name and address from 
Kabi Pharmacia, Inc., to Pharmacia, Inc.

EFFECTIVE DATE: March 31, 1995.

FOR FURTHER INFORMATION CONTACT: Benjamin A. Puyot, Center for 
Veterinary Medicine (HFV-130), Food and Drug Administration, 7500 
Standish Pl., Rockville, MD 20855, 301-594-1646.

SUPPLEMENTARY INFORMATION: Kabi Pharmacia, Inc., 800 Centennial Ave., 
Piscataway, NJ 08854, has informed FDA of a change of sponsor name and 
address from Kabi Pharmacia, Inc., to Pharmacia Inc., P.O. Box 16529, 
Columbus, OH 43216-6529. Accordingly, the agency is amending the 
regulations in 21 CFR 510.600(c)(1) and (c)(2) to reflect the change of 
sponsor name and address.

List of Subjects in 21 CFR Part 510

    Administrative practice and procedure, Animal drugs, Labeling, 
Reporting and recordkeeping requirements. [[Page 16571]] 
    Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
authority delegated to the Commissioner of Food and Drugs and 
redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is 
amended as follows:

PART 510--NEW ANIMAL DRUGS

    1. The authority citation for 21 CFR part 510 continues to read as 
follows:


    Authority: Secs. 201, 301, 501, 502, 503, 512, 701, 706, 721 of 
the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 331, 351, 
352, 353, 360b, 371, 376e).


    2. Section 510.600 is amended in the table in paragraph (c)(1) by 
removing the entry for ``Kabi Pharmacia, Inc.,'' and alphabetically 
adding a new entry for ``Pharmacia, Inc.,'' and in the table in 
paragraph (c)(2) in the entry for ``000016'' by revising the sponsor 
name and address to read as follows:

Sec. 510.600  Names, addresses, and drug labeler codes of sponsors of 
approved applications.

* * * * *

    (c) * * *

    (1) * * *


------------------------------------------------------------------------
                                                                   Drug 
                     Firm name and address                       labeler
                                                                   code 
------------------------------------------------------------------------
                      *      *      *      *      *                     
Pharmacia, Inc., P.O. Box 16529, Columbus, OH 43216-6529.......   000016
                      *      *      *      *      *                     
------------------------------------------------------------------------


    (2) * * *


------------------------------------------------------------------------
  Drug                                                                  
labeler                       Firm name and address                     
  code                                                                  
------------------------------------------------------------------------
                      *      *      *      *      *                     
000016.  Pharmacia, Inc., P.O. Box 16529, Columbus, OH 43216-6529       
                      *      *      *      *      *                     
------------------------------------------------------------------------


    Dated: March 21, 1995.

Robert C. Livingston,

Director, Office of New Animal Drug Evaluation, Center for Veterinary 
Medicine.

[FR Doc. 95-7865 Filed 3-30-95; 8:45 am]

BILLING CODE 4160-01-F